Lazard Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,264
Closed -$654K 2609
2024
Q4
$654K Sell
7,264
-366
-5% -$33K ﹤0.01% 1290
2024
Q3
$753K Buy
+7,630
New +$753K ﹤0.01% 1221